Zydus Lifesciences gets USFDA nod for generic acne-treating drugZydus Lifesciences received final approval from the US health regulator for its generic antibiotic Minocycline Hydrochloride extended-relea...
19 Jun, 2023, 04.22 PM IST
Sun Pharma expands tie-up with Cassiopea for acne cream to six countriesAs per the tie-up, the company will receive from Cassiopea the exclusive right to develop and commercialise WINLEVI in Japan, Australia, Ne...
26 Jul, 2022, 01.04 PM IST
Glenmark gets USFDA nod for acne treatment drugGlenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Ge...
11 Feb, 2021, 11.36 AM IST
Alembic Pharma gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals on Friday said its joint venture has received nod from the US health regulator for generic Adapalene gel used for t...
19 Jun, 2020, 02.48 PM IST
Lupin launches tablets in US to treat infectionsThe 75 mg and 150 mg tablets were launched after receiving the approval for the from the United States Food and Drug Administration (USFDA)...
02 Nov, 2017, 10.09 PM IST
Lupin gets USFDA nod to market anti-infections tabletsThe company has received final approval from the USFDA to market its Doxycycline hyclate tablets USP in the strength of 100 mg.
11 Sep, 2017, 02.59 PM IST
Cipher, Ranbaxy settle patent litigation with ActavisCipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical Research, has entered into a patent litiga...
05 Oct, 2015, 11.37 PM IST
Sun Pharma surges after USFDA approves drug application for acne treatmentSun Pharma surged over 3% in trade today after the drug major received approval from the US health regulator for its new drug.
20 Aug, 2015, 10.38 AM IST
Sun Pharma gets USFDA approval for acne drugSun Pharmaceutical Industries today said it has received approval from the US health regulator for its new drug application for acne treatm...
19 Aug, 2015, 09.42 PM IST
Sun-Ranbaxy $4 billion deal: US anti-trust regulator FTC passes final orderFTC has passed its final order settling charges that Sun Pharma's $4 billion deal to acquire Ranbaxy Laboratories could result in unfair bu...
20 Mar, 2015, 10.55 PM IST
Lupin gets USFDA nod to market generic version of CiproLupin said it has received US health regulator USFDA'S approval to market a generic version of Bayer's Cipro, used to treat infections, in ...
06 Mar, 2014, 06.46 PM IST
Ranbaxy sues Actavis in US; stock rallies over 3%At 06:35 pm; Ranbaxy pared some of the morning gains and was trading 1.9% higher at Rs 411.05.
04 Nov, 2013, 02.12 AM IST
Ranbaxy sues Actavis in US to prevent sale of acne genericAbsorica helped Ranbaxy shore up its sales in the US market in the September quarter. The drug commands 19% market share in the US.
02 Nov, 2013, 10.10 AM IST
Watson Laboratories send patent challenge notice to Ranbaxy for acne drugRanbaxy Laboratories' US arm has received a notice from Watson Laboratories, challenging the patent of acne treatment drug Absorica.
20 Sep, 2013, 03.07 PM IST
Take steps to stop use of adulterated drugs in India: Rajinder SacharFormer chief justice of Delhi High Court Rajinder Sachar has demanded that Indian authorities take steps to stop their use in the country.
15 May, 2013, 05.31 PM IST
Dr Reddy's gets USFDA nod for generic Zenatane capsulesCompany has launched Accutane (Isotretinoin Capsules ) in the strengths of 20 mg and 40 mg on Mar 28 following the approval by the USFDA.
29 Mar, 2013, 02.12 PM IST
- Lupin Pharmaceuticals gets final USFDA nod for generic antibiotics
The approval by the USFDA has been granted to the company's subsidiary, Lupin Pharmaceuticals Inc for tablets of 65 mg, 80 mg, 105 mg and 1...
02 Dec, 2011, 02.27 PM IST